This week's biggest finding is that a computer model found a five-drug combination that could keep lung function nearly perfect — and that's real hope for people living with IPF (a disease where the lungs slowly scar and stiffen).
FVC = how much air your lungs can push out. Higher % = healthier lungs. A typical IPF patient starts around 50–60%.
This is a computer model result — not a prescription. Always talk to your doctor before changing anything.
Researchers are working hard on IPF (short for idiopathic pulmonary fibrosis — a disease where the lungs slowly fill with scar tissue, making it harder to breathe). This week our database tracked 8,574 studies and 1,972 active clinical trials (real-world tests of new treatments in people). Most new research is coming from large teams in Russia and China, and many early findings are being shared quickly online before full review — which means more ideas are flowing faster than ever before.
The AI tested hundreds of drug combinations and found one standout mix of five treatments — including things that calm inflammation (swelling inside the body) and help healthy lung cells grow back. This combination kept FVC (a measure of how much air your lungs can hold) at 99.7% — meaning lung capacity stayed almost completely normal. That is an unusually strong result and scientists are now studying whether it could work in real patients.
One question to ask your lung doctor at your next visit: "Are there any clinical trials near me testing new drug combinations for IPF that I might be a good fit for right now?"